DURHAM, North Carolina, Oct. 12 -- Oncologist, a peer-reviewed journal from the Society for Translational Oncology that says it features diagnostic and therapeutic advances for cancer treatment, published research articles on the following topics in its September 2023 supplement edition (Vol. 38, Issue 1):

Oral Abstract Presentations:

* ORCHID: A phase II study of Olaparib in Metastatic Renal Cell Carcinoma Patients HarborIng a BAP1 or Other DNA Repair Gene Mutations

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products